Management of arsenic trioxide necrosis in the maxilla.
Garip
Hasan
H
Department of OMFS, Marmara University Faculty of Dentistry, Sisli/Istanbul, Turkey. hasangarip04@yahoo.com
Salih
Imad M
IM
Sener
B Cem
BC
Göker
Kamil
K
Garip
Yldz
Y
D000328:Adult; D016301:Alveolar Bone Loss / Q000209:etiology / Q000601:surgery; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D003787:Dental Pulp Devitalization / Q000009:adverse effects*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008439:Maxillary Diseases / Q000139:chemically induced / Q000601:surgery; D009957:Oroantral Fistula / Q000209:etiology / Q000601:surgery; D010020:Osteonecrosis / Q000139:chemically induced*; D010087:Oxides / Q000009:adverse effects*
D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide